Noviga Research
Manufacturing · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
J Forskargatan 20, Soedertaelje, Stockho...Website
www.novigaresearch.comRevenue
<$5 MillionIndustry
About Noviga Research
Is Noviga Research your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Noviga Research has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Noviga Research had a recent Job posting/layoffs
Earning: See what the market has to say on Noviga Research recently announced quarterly report
Noviga Research, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Noviga Research is spiking on competitors!
Product Launch: Get notified when Noviga Research launches new products
Check if Noviga Research has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Noviga Research
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Noviga Research is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Noviga Research is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Noviga Research.
Noviga Research Tech Stack
A closer look at the technologies used by Noviga Research
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Noviga Research
Noviga Research AB is a Swedish pharmaceutical company dedicated to developing innovative drugs for advanced cancer treatment. Their lead compound, NOV202, is undergoing regulatory toxicity and safety pharmacology studies, followed by clinical trials in patients with refractory cancer. The company has demonstrated promising results with NOV202 in c... Read More